Bancel Stephane — SEC Form 4 filings
SEC reporting owner CIK 1443340. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-16 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 160,314 shares, $5,004,318 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 525,597 shares, $31,057,109 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 187,044 shares @ $58.79 ($10,996,317) in Moderna, Inc., filed 2026-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | Chief Executive Officer, Director | 10 | 2 legs · 160,314 sh · $5,004,318 | 5 legs · 525,597 sh · $31,057,109 | 17 |
| Generate Biomedicines, Inc. (GENB) | Director | 1 | — | — | 3 |
Form 4 filings — Bancel Stephane
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 499,246 @ $19.15 · Sale (S): 147,473 @ $56.21 · Sale (S): 124,838 @ $56.96 · Sale (S): 39,891 @ $58.12 · Sale (S): 187,044 @ $58.79 · Option exercise (M): 252,469 @ $19.15 · +4 more | EDGAR |
| 2026-03-03 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 250,932 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Generate Biomedicines, Inc. (GENB) | Conversion (C): 724,160 · Grant/award (A): 29,561 (derivative) @ $0 · Conversion (C): 1,100,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 11,271 @ $0 · Tax withholding (F): 5,450 @ $41.99 | EDGAR |
| 2025-12-15 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 688,073 @ $10.90 · Option exercise (M): 688,073 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Moderna, Inc. (MRNA) | Purchase (P): 102,821 @ $31.04 · Purchase (P): 57,493 @ $31.53 | EDGAR |
| 2025-03-03 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 357,065 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 13,233 @ $0 · Tax withholding (F): 6,400 @ $30.93 | EDGAR |
| 2024-06-17 | 4 | Moderna, Inc. (MRNA) | Other (J): 26,840 @ $0 | EDGAR |
| 2024-02-29 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 151,943 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 56,736 @ $0 · Sale (S): 26,351 @ $88.88 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1443340 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →